These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 3835609)
21. [Hemodynamic effects of the administration of nifedipine over an 18-month period in pulmonary arterial hypertension in chronic obstructive bronchopneumopathies]. Vestri R; Joet FP; Saadjian A; Arnaud A Presse Med; 1988 Feb; 17(5):213-4. PubMed ID: 2965386 [No Abstract] [Full Text] [Related]
23. The effects of hydralazine on exercise capacity in pulmonary hypertension secondary to chronic obstructive pulmonary disease. Dal Nogare AR; Rubin LJ Am Rev Respir Dis; 1986 Mar; 133(3):385-9. PubMed ID: 3954247 [TBL] [Abstract][Full Text] [Related]
24. [Hypoxia and pulmonary circulation. The importance of hypoxia in pulmonary arterial hypertension of chronic obstructive bronchopneumopathies]. Weitzenblum E; Oswald-Mammosser M; Apprill M; Kessler R; Ehrhart M Rev Mal Respir; 1988; 5(4):381-7. PubMed ID: 3175264 [TBL] [Abstract][Full Text] [Related]
25. Pulmonary hypertension in COPD: a review and consideration of the role of arterial vasodilators. Burger CD COPD; 2009 Apr; 6(2):137-44. PubMed ID: 19378227 [TBL] [Abstract][Full Text] [Related]
26. [Pulmonary hypertension in chronic obstructive lung disease. Hemodynamic changes induced by oxygen, verapamil, and isoproterenol acute administration (author's transl)]. Sclavo M; Bucca C; Rolla G; Borello G; Balbi L; Angelino PF G Ital Cardiol; 1981; 11(5):634-42. PubMed ID: 7286534 [No Abstract] [Full Text] [Related]
27. Vasodilators in patients with chronic obstructive pulmonary disease and pulmonary hypertension: not ready for prime time! Humbert M; Simonneau G Am J Respir Crit Care Med; 2010 Feb; 181(3):202-3. PubMed ID: 20093654 [No Abstract] [Full Text] [Related]
28. Vasodilators ineffective in secondary pulmonary hypertension. Dash H; Ballentine N; Zelis R N Engl J Med; 1980 Oct; 303(18):1062-3. PubMed ID: 7421904 [No Abstract] [Full Text] [Related]
29. [Decompensated pulmonary heart: topical aspects of management]. Kazanbiev NK Klin Med (Mosk); 1996; 74(4):11-4. PubMed ID: 8999141 [No Abstract] [Full Text] [Related]
30. [Primary pulmonary hypertension. An overview with special reference to risk-benefit analysis of therapy]. Schilling W Z Erkr Atmungsorgane; 1991; 177(3):117-34. PubMed ID: 1808861 [TBL] [Abstract][Full Text] [Related]
31. [Nifedipine treatment of pulmonary hypertension as a complication of chronic obstructive diseases of the lungs]. Paleev NR; Tsa'rkova LN; Uribe-Echevarria EE; Baklykova SN; Novoderezhkina LB Klin Med (Mosk); 1989 Jun; 67(6):117-20. PubMed ID: 2674536 [No Abstract] [Full Text] [Related]
32. [How to manage the patients with hypoxic pulmonary hypertension?]. Lewczuk J; Ludwik B Pol Merkur Lekarski; 2005 Oct; 19(112):567-70. PubMed ID: 16379328 [TBL] [Abstract][Full Text] [Related]
33. [Nitric oxide in the treatment of pulmonary artery hypertension induced by chronic obstructive pulmonary diseases]. He Q Zhonghua Yi Xue Za Zhi; 1996 Aug; 76(8):565-6. PubMed ID: 9275465 [No Abstract] [Full Text] [Related]
34. Does pulmonary arterial hypertension influence the prognosis in patients with chronic obstructive lung disease? Bishop JM Cor Vasa; 1985; 27(2-3):172-6. PubMed ID: 4028733 [No Abstract] [Full Text] [Related]